These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15721418)

  • 1. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study.
    Fagotti A; Fanfani F; Ludovisi M; Lo Voi R; Bifulco G; Testa AC; Scambia G
    Gynecol Oncol; 2005 Mar; 96(3):729-35. PubMed ID: 15721418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
    Fagotti A; Ferrandina G; Fanfani F; Ercoli A; Lorusso D; Rossi M; Scambia G
    Ann Surg Oncol; 2006 Aug; 13(8):1156-61. PubMed ID: 16791447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
    Fagotti A; Ferrandina G; Fanfani F; Garganese G; Vizzielli G; Carone V; Salerno MG; Scambia G
    Am J Obstet Gynecol; 2008 Dec; 199(6):642.e1-6. PubMed ID: 18801470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.
    Fagotti A; Vizzielli G; Fanfani F; Costantini B; Ferrandina G; Gallotta V; Gueli Alletti S; Tortorella L; Scambia G
    Gynecol Oncol; 2013 Nov; 131(2):341-6. PubMed ID: 23938372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
    Vergote I; Tropé CG; Amant F; Kristensen GB; Ehlen T; Johnson N; Verheijen RH; van der Burg ME; Lacave AJ; Panici PB; Kenter GG; Casado A; Mendiola C; Coens C; Verleye L; Stuart GC; Pecorelli S; Reed NS; ;
    N Engl J Med; 2010 Sep; 363(10):943-53. PubMed ID: 20818904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
    Onda T; Satoh T; Ogawa G; Saito T; Kasamatsu T; Nakanishi T; Mizutani T; Takehara K; Okamoto A; Ushijima K; Kobayashi H; Kawana K; Yokota H; Takano M; Kanao H; Watanabe Y; Yamamoto K; Yaegashi N; Kamura T; Yoshikawa H;
    Eur J Cancer; 2020 May; 130():114-125. PubMed ID: 32179446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
    Rutten MJ; van Meurs HS; van de Vrie R; Gaarenstroom KN; Naaktgeboren CA; van Gorp T; Ter Brugge HG; Hofhuis W; Schreuder HW; Arts HJ; Zusterzeel PL; Pijnenborg JM; van Haaften M; Fons G; Engelen MJ; Boss EA; Vos MC; Gerestein KG; Schutter EM; Opmeer BC; Spijkerboer AM; Bossuyt PM; Mol BW; Kenter GG; Buist MR
    J Clin Oncol; 2017 Feb; 35(6):613-621. PubMed ID: 28029317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
    Fagotti A; Ferrandina G; Vizzielli G; Fanfani F; Gallotta V; Chiantera V; Costantini B; Margariti PA; Gueli Alletti S; Cosentino F; Tortorella L; Scambia G
    Eur J Cancer; 2016 May; 59():22-33. PubMed ID: 26998845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
    Kehoe S; Hook J; Nankivell M; Jayson GC; Kitchener H; Lopes T; Luesley D; Perren T; Bannoo S; Mascarenhas M; Dobbs S; Essapen S; Twigg J; Herod J; McCluggage G; Parmar M; Swart AM
    Lancet; 2015 Jul; 386(9990):249-57. PubMed ID: 26002111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review.
    Fukunishi Y; Yanazume S; Nagata C; Mizuno M; Togami S; Kobayashi H
    Cureus; 2024 Jul; 16(7):e65415. PubMed ID: 39184721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis.
    Tozzi F; Matthys R; Molnar A; Ceelen W; Vankerschaver J; Rashidian N; Willaert W
    Ann Surg Oncol; 2024 Oct; 31(10):7165-7183. PubMed ID: 38918326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of minimally invasive surgery in epithelial ovarian cancer treatment: a narrative review.
    Generali M; Annunziata G; Pirillo D; D'Ippolito G; Ciarlini G; Aguzzoli L; Mandato VD
    Front Med (Lausanne); 2023; 10():1196496. PubMed ID: 37387787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.
    Pinto P; Burgetova A; Cibula D; Haldorsen IS; Indrielle-Kelly T; Fischerova D
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer.
    Lee YJ; Chung YS; Lee JY; Nam EJ; Kim SW; Kim YT; Kim S
    J Gynecol Oncol; 2023 Mar; 34(2):e17. PubMed ID: 36562129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates on fluorescent probes and open-field imaging methods for fluorescence-guided cytoreductive surgery for epithelial ovarian cancer: A review.
    Sun C; Huang Y; Jiang C; Li Z
    BJOG; 2022 Nov; 129 Suppl 2(Suppl 2):50-59. PubMed ID: 36485071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic Surgery for Ovarian Neoplasms - What is Possible, What is Useful?
    Droste A; Anic K; Hasenburg A
    Geburtshilfe Frauenheilkd; 2022 Dec; 82(12):1368-1377. PubMed ID: 36467976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectosigmoid sparing en bloc pelvic resection for fixed ovarian tumors: Surgical technique and perioperative and oncologic outcomes.
    Shan Y; Jin Y; Li Y; Gu Y; Wang W; Pan L
    Front Oncol; 2022; 12():980050. PubMed ID: 36072802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients.
    Saffarieh E; Nassiri S; Mirmohammadkhani M
    Eur J Transl Myol; 2022 Aug; 32(3):. PubMed ID: 35916763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer.
    Kim SI; Kim JW
    ESMO Open; 2021 Jun; 6(3):100149. PubMed ID: 33984680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of optimal debulking surgery in ovarian cancer.
    Song YJ
    Gland Surg; 2021 Mar; 10(3):1173-1181. PubMed ID: 33842263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.